Certolizumab Pegol for Treatment of Plaque Psoriasis: Pooled Three-Year Efficacy Outcomes from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2). (2019). SKIN The Journal of Cutaneous Medicine, 3, S37. https://doi.org/10.25251/skin.3.supp.37